Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Koll

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Cells|February 25, 2023
Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder CancerFlorestan J Koll, Eric Metzger, Jana Hamann, et al.
Frontiers in Medicine|July 5, 2022
CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative CasesFlorestan J Koll, Alina Schwarz, Jens Köllermann, et al.
International Journal of Molecular Sciences|September 9, 2022
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse ModelMoritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
Journal of Clinical Pathology|November 21, 2023
Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancerFlorestan J Koll, Claudia Döring, Leon Herwig, et al.
BMC Cancer|January 5, 2020
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)Sebastian C Schmid, Florestan J Koll, Claus Rödel, et al.
BMC Research Notes|May 15, 2024
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based studyLisa Falchetto, Bernd Bender, Ian Erhard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary TractRayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Nature|February 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature|December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Physical Review Letters|December 11, 2012
Search for direct top squark pair production in final states with one isolated lepton, jets, and missing transverse momentum in sqrt[s] = 7 TeV pp collisions using 4.7 fb(-10 of ATLAS dataG Aad, T Abajyan, B Abbott, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Cells|February 25, 2023
Overexpression of KMT9α Is Associated with Aggressive Basal-like Muscle-Invasive Bladder CancerFlorestan J Koll, Eric Metzger, Jana Hamann, et al.
Frontiers in Medicine|July 5, 2022
CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative CasesFlorestan J Koll, Alina Schwarz, Jens Köllermann, et al.
International Journal of Molecular Sciences|September 9, 2022
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse ModelMoritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
Journal of Clinical Pathology|November 21, 2023
Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancerFlorestan J Koll, Claudia Döring, Leon Herwig, et al.
BMC Cancer|January 5, 2020
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)Sebastian C Schmid, Florestan J Koll, Claus Rödel, et al.
BMC Research Notes|May 15, 2024
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based studyLisa Falchetto, Bernd Bender, Ian Erhard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary TractRayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Nature|February 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Nature|December 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIgnacio Melero, Maria de Miguel Luken, Guillermo de Velasco, et al.
Physical Review Letters|December 11, 2012
Search for direct top squark pair production in final states with one isolated lepton, jets, and missing transverse momentum in sqrt[s] = 7 TeV pp collisions using 4.7 fb(-10 of ATLAS dataG Aad, T Abajyan, B Abbott, et al.
Pageof 11